Zim Laboratories Q1 FY27 Results (NSE: ZIMLAB)

· Analysis by Alpha Inflection

Signal: Loss widened

Zim Laboratories Q1 FY27 key financials
MetricValueYoYQoQ
Revenue₹0.94 Cr31.3%-10.5%
EBIT₹-0.02 CrN/A
Net profit₹-0.04 CrN/A
EPS₹-0.75N/A
EBIT margin-2.0%

P&L walk

Revenue surged 31% YoY but gross margin collapsed as raw material cost ratio jumped ~780bps, driving EBITDA margin to 3.7% (down 470bps YoY); elevated depreciation (+10.5% YoY) and finance cost (+10.3% YoY) pushed PBT deep into loss; net loss widened to ₹4.02 Cr from ₹1.87 Cr loss a year ago.

View original filing

Research and educational content only. Not investment advice.